146 results
Page 4 of 8
8-K
EX-10.2
invyh0yd w66zjr39ess
9 Sep 20
Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer
9:30am
8-K
EX-10.1
p2obotgm47 kxgmt
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm
424B5
r832f7
19 May 20
Prospectus supplement for primary offering
5:29pm
8-K
EX-99.1
2q48encd 72nmu
11 May 20
Diffusion Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
4:58pm
8-K
EX-99.1
y9nyghp ffng5mdazv65
24 Mar 20
Diffusion Pharmaceuticals Anticipates Enrollment in its Ambulance-based Stroke Trial Will be Slowed Due to the Impact of the Coronavirus
4:41pm
8-K
EX-99.1
y7ay2g
18 Mar 20
Diffusion Pharmaceuticals Announces Retirement of Chief Science Officer John L. Gainer
5:22pm
8-K
EX-99.1
u3upamhd596qs ngh2w
13 Jan 20
Diffusion Pharmaceuticals Appoints Life Sciences Veteran Dr. Robert Cobuzzi, Jr. to its Board of Directors
4:16pm
424B3
1ex2cmhhh23a9ei 2ygd
30 Dec 19
Prospectus supplement
10:07am
8-K
vz1g770y5fjau7a43g
20 Dec 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:08pm
8-K
EX-10.1
7zkwcanb88rs7p
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
424B5
94hib v6mg9
13 Dec 19
Prospectus supplement for primary offering
7:59am
8-K
nctnw3g 4l2
11 Dec 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
3:15pm
424B4
7rl3oqv 04
15 Nov 19
Prospectus supplement with pricing info
12:00am
8-K
EX-10.2
gn1aeftyqv6bb le
13 Nov 19
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
5:00pm